Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Regenerative Therapy is Scopus-indexed (Q2, CiteScore 5.3), WoS SCIE, DOAJ. Published by Japanese Society of Regenerative Medicine.
Checked against the index lists dated .
ISSN 2352-3204Verify ISSN ↗
Publisher: Japanese Society of Regenerative Medicine
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Developmental Biology | 31 / 78 | 60th | Q2 |
| Biomedical Engineering | 145 / 342 | 57th | Q2 |
| Biomaterials | 76 / 146 | 48th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2015–present, best quartile Q2, CiteScore 5.3.
Regenerative Therapy is Q2 in Developmental Biology (rank 31 of 78), Q2 in Biomedical Engineering (rank 145 of 342) and Q3 in Biomaterials (rank 76 of 146), by CiteScore 2025.
Regenerative Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.3, which places it in quartile Q2 at the 60th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.836, quartile Q2, with an H-index of 42.
The publisher lists an article processing charge of about US$1,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Regenerative Therapy is published by Japanese Society of Regenerative Medicine. Its ISSN is 2352-3204.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Regenerative Therapy has an h-index of 49 and a 2-year mean of 5.22 citations per paper (OpenAlex). Its Scopus CiteScore is 5.3, quartile Q2. On 2-year citations it ranks #12 of 76 Scopus journals in Developmental Biology.
Regenerative Therapy published 221 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from Japan (52.3%), China (23.6%) and Iran (3.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (1.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.